Posted by Michael Wonder on 13 Mar 2026

MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults

UK Government

12 March 2026 - The MHRA has approved deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults.

Deuruxolitinib was approved on 10 March 2026 to Sun Pharma.

Read UK Government press release  

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , England , Medicine , Registration